1. Peripheral blood mitochondrial DNA content, A10398G polymorphism, and risk of breast cancer in a Han Chinese population
   Huangang Jiang et al, 2014, Cancer Science CrossRef
2. Elevated Mitochondrial DNA Copy Number in Peripheral Blood and Tissue Predict the Opposite Outcome of Cancer: A Meta-Analysis
   Nan Chen et al, 2016, Scientific Reports CrossRef
3. Understanding Mitochondrial Polymorphisms in Cancer
   Karen M. Bussard et al, 2017, Cancer Research CrossRef
4. Correlation Analysis between mtDNA G10398A Polymorphism and Susceptibility of Patients with Type 2 Diabetes Mellitus in Northwest China
   Xie Xiao-Dong, 2016, Open Journal of Biological Sciences CrossRef
5. Mitochondrial DNA in Lung Cancer
   Fangming Liu et al, 2017, Mitochondrial DNA and Diseases CrossRef
6. Emerging methods for and novel insights gained by absolute quantification of mitochondrial DNA copy number and its clinical applications
   Brian Li et al, 2022, Pharmacology & Therapeutics CrossRef
7. Subhaplogroup D4b1 enhances the risk of cervical cancer initiation: A case‐control study in southern China
   Yuanyan Li et al, 2016, Journal of Obstetrics and Gynaecology Research CrossRef
8. Involvement of increased p53 expression in the decrease of mitochondrial DNA copy number and increase of SUVmax of FDG-PET scan in esophageal squamous cell carcinoma
   Chen-Sung Lin et al, 2019, Mitochondrion CrossRef
9. Distinct radiation responses after in vitro mtDNA depletion are potentially related to oxidative stress
   Marike W. van Gisbergen et al, 2017, PLOS ONE CrossRef
10. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation
    Su Yeon Lee et al, 2017, Molecular Cancer CrossRef
11. Mitochondrial Heteroplasmy Shifting as a Potential Biomarker of Cancer Progression
    Carlos Jhovani Pérez-Amado et al, 2021, International Journal of Molecular Sciences CrossRef
12. Direct confirmation of quiescence of CD34+CD38- leukemia stem cell populations using single cell culture, their molecular signature and clinicopathological implications
    Eun Jeong Won et al, 2015, BMC Cancer CrossRef
13. Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management
    Anton M.F. Kalsbeek et al, 2017, Oncotarget CrossRef
14. Spotlight on the relevance of mtDNA in cancer
    A. Cruz-Bermúdez et al, 2017, Clinical and Translational Oncology CrossRef
15. Simultaneous quantification of DNA damage and mitochondrial copy number by long-run DNA-damage quantification (LORD-Q)
    Benjamin Dannenmann et al, 2017, Oncotarget CrossRef
16. Heteroplasmy of mutant mitochondrial DNA A10398G and analysis of its prognostic value in non-small cell lung cancer
    Yuexiao Qi et al, 2016, Oncology Letters CrossRef
17. Variable alterations of mitochondrial microsatellite instability and DNA copy number in pulmonary hamartomas
    Deok Heon Lee et al, 2017, Cancer Biomarkers CrossRef
18. Qualitative and quantitative changes in mitochondrial DNA associated with cervical cancer: A comprehensive review
    Isadora Oliveira Ansaloni Pereira et al, 2024, Environmental and Molecular Mutagenesis CrossRef
19. Mitochondria transcription and cancer
    Tang Lei et al, 2024, Cell Death Discovery CrossRef
20. The Role of Mitochondria in Carcinogenesis
    Paulina Kozakiewicz et al, 2021, International Journal of Molecular Sciences CrossRef
21. An association analysis between mitochondrial DNA content, G10398A polymorphism, HPV infection, and the prognosis of cervical cancer in the Chinese Han population
    Dali Feng et al, 2016, Tumor Biology CrossRef
22. Mitochondrial Dysfunctions Regulated Radioresistance through Mitochondria-to-Nucleus Retrograde Signaling Pathway of NF-κB/PI3K/AKT2/mTOR
    Yuehua Wei et al, 2018, Radiation Research CrossRef
23. Mitochondrial DNA Haplotypes as Genetic Modifiers of Cancer
    Alpaslan Tasdogan et al, 2020, Trends in Cancer CrossRef